{
    "2021-03-08": [
        [
            {
                "time": "",
                "original_text": "金域医学(603882.SH)收到中国证监会关于非公开发行股票的批复",
                "features": {
                    "keywords": [
                        "金域医学",
                        "非公开发行",
                        "股票",
                        "证监会",
                        "批复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "金域医学：截至2月底，公司已累计开展核酸检测超5900万人份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "核酸检测",
                        "累计",
                        "2月底"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "金域医学：证监会核准公司非公开发行不超过约312万股新股",
                "features": {
                    "keywords": [
                        "金域医学",
                        "非公开发行",
                        "新股",
                        "证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)定增申请获中国证监会核准",
                "features": {
                    "keywords": [
                        "金域医学",
                        "定增",
                        "证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药周报：坚守具备估值安全垫、业绩增长确定性高的二龙头",
                "features": {
                    "keywords": [
                        "医药",
                        "估值安全垫",
                        "业绩增长",
                        "二龙头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业：调整是布局良机 重点新冠疫苗加速接种带来的投资机会",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "调整",
                        "布局",
                        "新冠疫苗",
                        "加速接种",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}